Abstract
The gastrointestinal lumen is home to over 400 species of microorganisms. The composition of this microbial community varies along the length of the gastrointestinal tract as a function of regional epithelial secretory activity as well as diet and other defined and undefined determinants. Improved understanding of the factors that impact luminal microbial populations and development of means to modulate gut microbes for therapeutic benefit hold great promise. The gastrointestinal epithelium, which regulates interactions between microbes and the mammalian host, is the topic of this review.
Key words: intestine, epithelium, secretion, absorption, tight junction, myosin, microbes
Introduction
Like the skin, the gastrointestinal tract creates a barrier between external and internal environments. However, the gastrointestinal tract is also responsible for nutrient absorption and digestion, and in many areas is densely colonized by microbes. Because of these facts, the management of this barrier requires mechanisms far more complex than those required by the skin. The discussion that follows will address common and divergent approaches used to balance these requirements in different regions of the gastrointestinal tract.
The overall structure of the gastrointestinal wall is preserved throughout the tract and, with the exception of the esophagus, the gut is lined by a single layer of columnar epithelial cells. In contrast, stratified (multi-layered) squamous cells line the esophagus (Fig. 1A). Like the skin, these squamous cells form a significant barrier and, with the exception of lubricating secretions from the submucosal glands, the esophagus acts as a simple conduit that delivers masticated food from the oral cavity to the stomach. However, colonization by fungi and bacterial organisms is relatively common, particularly if the surface epithelium is superficially eroded or more deeply ulcerated. While pathological, such infections are rarely invasive and, therefore, do not typically result in systemic consequences. Other infections, including by herpes virus and cytomegalovirus, also occur, particularly in immunosuppressed individuals.
Figure 1.

Epithelial organization. (A) The esophageal (and anal) mucosae are covered by a stratified squamous epithelium. Stem cells reside in the basal zone (arrow) and proliferate to give rise to cells that divide and populate the epithelium. Mitoses are rare above the bottom one-third of the stratified epithelium. Squamous cells terminally differentiate and are shed at the luminal surface (arrowhead). Hematoxylin and eosin stain. (B) The colonic mucosa, and the majority of the gastrointestinal tract, is covered by a simple columnar epithelium. Stem cells reside in the crypts (arrow) and proliferate as they migrate towards the surface. Mitoses are rare beyond this transit-amplifying zone, which occupies the bottom one-third of the mucosal thickness. Terminally-differentiated surface cells (arrowhead) are shed at the luminal surface. The loose connective tissue surrounding the crypts is termed the lamina propria. Hematoxylin and eosin stain.
Within the remainder of the gastrointestinal tract, the simple columnar epithelium (Fig. 1B) rests on a basement membrane and the loose connective tissue of the lamina propria. Lymphocytes, mast cells, macrophages and polymorphonuclear leukocytes populate the lamina propria, which is supported by a thin layer of smooth muscle termed the muscularis mucosa. Together, the epithelium, lamina propria and muscularis mucosa make up the mucosa, which overlays the submucosa composed of fibroconnective tissue, nerves, vessels and lymphatics. While the submucosa supports the mucosa, the muscularis propria—two, or in the stomach three, layers of smooth muscle—supports the submucosa. In most areas, a thin layer of fibrofatty tissue and the surface mesothelial cells form a serosa that encases the gastrointestinal tract. However, in some regions of the esophagus and the distal colorectum, fibrofatty tissue beneath the muscularis propria extends directly into regional connective tissue and no serosa is present.
As the microscopic anatomy of the gastrointestinal tract differs along its length, the commensal and infectious microbes that inhabit each region vary. Thus, an appreciation of region-specific anatomy is necessary for one to understand interactions between microbes and the gut.
Stomach
The gross and microscopic anatomies of the stomach reflect its two major functions: mixing of food with acid, digestive enzymes and fluid to transform it into semi-liquid chyme, and regulation of the passage of this partially-digested material into the duodenum. The mucosa and submucosa of the contracted stomach are piled into folds called rugae. As the stomach expands with food content, the rugae flatten themselves to accommodate the increased volume. On a cellular level, the mucosa contains a network of gastric glands that empty into overlying pits. The glands and pits are extensive in the acid secreting, or oxyntic, fundus and body of the stomach. In these regions, the glands and pits are largely populated by parietal cells, which secrete acid and intrinsic factor, as well as the exocrine chief cells that secrete pepsinogen (Fig. 2A). Once secreted, pepsinogen is cleaved to form pepsin, a protease that contributes to the initial phase of digestion.
Figure 2.

Stomach. (A) The pits house the specialized cells that are responsible for gastric function. The pale, pink parietal cells (arrowhead) secrete acid, while the blue chief cells (arrow) secrete digestive enzymes. Hematoxylin and eosin stain. (B) Helicobacter pylori micro-colonies (arrowhead) grow in the mucous layer secreted by the gastric surface foveolar cells. Steiner silver stain.
The gastric surface is populated by foveolar cells that secrete mucin and bicarbonate. These components work together with the unstirred layer to form a region that is markedly less acidic than the lumen,1 which typically has a pH between 1 and 2. Thus, this mucus-rich layer is also an ecological niche that allows growth of the most common gastric pathogen, Helicobacter pylori (Fig. 2B). Bacterial production of the enzyme urease buffers and elevates local pH by cleaving urea to generate ammonia. While many bacteria may synthesize urease, the enzyme produced by H. pylori has a low Km that allows function in the low urea concentrations present in the stomach. This permits identification of H. pylori by the CLO (Campylobacter-like organism) test, in which a gastric mucosal biopsy is cultured in a urea-containing gel. Change in color of the pH indicator included within the gel indicates the presence of urease-containing bacteria. H. pylori urease may also regulate epithelial paracellular permeability via myosin light chain kinase activation and occludin internalization2 using mechanisms that are thought to be similar to tumor necrosis factor-induced regulation of intestinal epithelial tight junctions (described below).
H. pylori are most often found in the gastric antrum and cardia, likely reflecting the absence of parietal cells and active mucosal acid secretion in these areas. However, in patients with gastric mucosal atrophy, which may occur in chronic gastritis, parietal and chief cells may be lost, allowing H. pylori colonization of the fundus and body. Repopulation of parietal and chief cells is difficult, as these cells are normally replaced every 1 to 3 years, while foveolar cells repopulate rapidly, with the entire surface epithelium renewed every 4 to 8 days. Thus, mucosal atrophy is a longstanding condition that is associated with reduced gastric acid secretion and may proceed to intestinal metaplasia, in which foveolar mucous cells are replaced by intestinal-type goblet cells. Perhaps because of cell type-specific bacterial adhesins, H. pylori are unable to bind to goblet cells and are rarely found in areas of extensive intestinal metaplasia. Similarly, H. pylori are never found in the duodenum. Thus, although intestinal metaplasia is a risk factor for the ultimate development of adenocarcinoma, it may have its origins as an adaptive response to H. pylori infection.3
Small Intestine
The small intestine is divided anatomically into three segments: the duodenum, jejunum and ileum. While these are similar anatomically, there is a gradient of specialized function, such that water soluble vitamins and fatty acids are absorbed in the duodenum, glucose and Na+ are most effectively absorbed in the jejunum, and vitamin B12 and bile salts are absorbed in the ileum. Although incompletely defined, there is also a gradient of bacterial colonization in the small intestine, with the duodenal contents containing far fewer organisms than those of the ileum. The ileocecal valve limits reflux of colonic contents, which includes an even greater bacterial load, into the ileum. However, the ileocecal valve is not absolutely required, as patients who have undergone right hemicolectomy for cancer, in which the distal ileum is anastamosed directly to the colon, are not at increased risk for infection or inflammatory disease.
Throughout the small intestine, the mucosa and submucosa are specialized to increase surface area and maximize the absorptive capabilities of the mucosa. The submucosa is organized into regular mucosal folds as well as villi that increase the overall surface area 30-fold. At the core of each villus (Fig. 3A) lies a central arteriole from which capillaries fan out and descend just beneath the basement membrane. This intimate association between central arteriole and descending capillaries allows for the countercurrent exchange of solutes, comparable to that which occurs in the renal medulla. Thus, the villous lamina propria becomes hypertonic during active nutrient absorption, and this serves to enhance bulk fluid absorption.4 The center of each villus also contains a lacteal that allows chylomicrons and other lipids to be trafficked after transepithelial absorption. The cellular components of the lamina propria normally include lymphocytes and plasma cells (Fig. 4A). However, these are replaced by dense macrophage infiltrate in mycobacterial infection (Fig. 4B), which results in lymphatic compression, disruption of lipid absorption, and steatorrhea (excessive stool fat content). The rich lymphatic network in the small intestine can also have a dark side, as it may also provide a route for small, superficially invasive cancers to metastasize or be a conduit that delivers metastatic tumors from other sites (Fig. 4C).
Figure 3.

Small intestine. (A) This low magnification view shows the overall organization of crypts (arrow) and villi. Cells are shed from the villus tip (arrowhead). Hematoxylin and eosin stain. (B) High magnification view of villus tip. Note the refractile microvillus brush border (arrowhead). Hematoxylin and eosin stain. (C) High magnification view of a crypt. Paneth cells have large red granules (arrow) within the apical cytoplasm, while enteroendocrine cells (arrowhead) have much smaller, basally oriented granules. Hematoxylin and eosin stain.
Figure 4.
Lamina propria. (A) The small intestinal lamina propria is populated by vessels, lymphatics, lymphocytes and plasma cells (arrowhead). Hematoxylin and eosin stain. (B) In mycobacterial infection, macrophages (arrowhead) become filled with organisms (reddish in acid fast stain, inset). Hematoxylin and eosin stain. (C) This neuroendocrine carcinoma (arrowhead) has filled the lamina propria lymphatics. Hematoxylin and eosin stain.
Like the specialization from duodenum to jejunum, there is functional compartmentalization from crypt to villus. The crypts, which are derived from a single progenitor cell,5 are responsible for cell renewal and both exocrine and endocrine-paracrine secretion. Each crypt contains four to six stem cells,6 which can be identified by their expression of Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) or olfactomedin-4.7,8 While the functions of these and other proteins9 in stem cell maintenance is not yet clear, they are useful as markers of this niche,6,10 which may be the source of transformed cells in cancer.11,12 Stem cells divide and differentiate into Paneth cells and enteroendocrine cells that also populate the intestinal crypt (Fig. 3C). Recent studies have suggested that Paneth cells are essential components of the crypt cell niche,6 and this may explain their increased numbers in chronic inflammatory disease. Paneth cells also release defensins, antimicrobial peptides that regulate microbial populations within the gut13 and provide protection from bacterial toxins.14 Together with defensins, fluid secretion (discussed below) allows the crypt lumen to be a relatively sterile site.
The progeny of stem cells emerge from the basal aspect of the crypt as undifferentiated, transit-amplifying cells. These cells secrete chloride into the lumen in response to a broad spectrum of extracellular stimuli, including adenosine and cholera toxin, using calcium and cyclic nucleotides as intracellular mediators.15–18 This chloride secretion establishes an osmotic gradient that draws sodium and water across the tight junction, resulting in net fluid secretion.19–22 Under normal conditions, the undifferentiated crypt cells mature into mucin-secreting goblet cells and absorptive enterocytes that express nutrient and ion transporters as they proliferate and migrate to the villus tip (Fig. 3B).23–25 These cells have a well developed brush border covered by a dense forest of ∼1 µm-tall microvilli that increase the absorptive surface area 20-fold, thereby significantly increasing the density of transmembrane transporter proteins and efficiency of nutrient absorption. Disruption of microvilli by attaching and effacing organisms, such as enteropathogenic E. coli, is one means by which these pathogens may cause malabsorption and diarrhea.
Each microvillus is by supported a cytoskeletal core of actin filaments and associated proteins, including myosin I and villin. As these cytoskeletal cores protrude into the cell body, they meet the terminal web, a dense mesh of microfilaments enriched in myosin II. At the periphery of the cell, the terminal web condenses to form a perijunctional actomyosin ring that is closely associated with the adherens and tight junctions. As detailed below, the perijunctional actomyosin ring is critical to tight junction assembly, maintenance and regulation.
Ultimately, epithelial cells are shed into the lumen, allowing the intestinal epithelial to turn over completely every 4 to 8 days. Debate continues as to whether apoptosis triggers shedding or detachment from the basement membrane triggers anoikis.26 In either case, it is clear that the epithelial barrier is preserved during cell shedding.27,28 The mechanisms by which barrier maintenance and epithelial apoptosis are coordinately regulated are an area in need of further study.
Due to the diversity of dietary and microbial antigens present in the lumen, the gut is the primary site at which the immune system encounters the external environment. The small intestine includes several specialized features that facilitate this sampling. The first, M (microfold-bearing) cells are present in the epithelium that covers lymphoid follicles.29–32 While most prevalent in the distal ileum overlying the Peyer's patches, M cells are present throughout the small intestine and colon. M cells cannot be recognized by light microscopy, but transmission electron microscopy reveals irregular, short and sparse microvilli and a basal membrane that retracts from the basement membrane to form a space. Lymphocytes and macrophages migrate into this space, where the M cells release the contents of apically derived endocytic vesicles. This transcytosis is a rapid and efficient conduit for infectious organisms, such as Salmonella spp., Listeria monocytogenes and Shigella flexneri, and has also been exploited for mucosal vaccine delivery.29 Within the distal ileum, an additional mechanism of luminal sampling is used by a specialized population of dendritic cells that extend processes across the epithelial tight junction.33–35 The overall contribution of these processes to mucosal immune function is poorly understood.
Colon
The colon absorbs excess water and salts and serves as a reservoir to hold fecal material until defecation. Microbial populations are far denser than in the small intestine, and can exceed 1012 bacteria per milliliter. As is true throughout the gut, the majority of these bacteria are anaerobes, reflecting the anoxic lumen.
Colonic bacteria are symbiotic with the mammalian host and can break down complex carbohydrates that cannot be metabolized by humans.36–38 Moreover, fermentation by bacteria generates short chain fatty acids that serve as an important energy source for colonic epithelial cells.39 Deprivation of the fecal stream and resultant alterations of luminal microbial populations may, in part, explain the colitis that develops in excluded segments of distal colon when a proximal ostomy is created.40 This diversion colitis generally abates when fecal flow is restored.
The colonic mucosa is organized into parallel crypts that mature into a flat surface that lacks villi. Both crypt and surface epithelium are composed primarily of goblet cells. While goblet cell function is not thought to vary greatly along the crypt-surface axis, the scattered columnar colonocytes tend to be secretory towards the bottom of the crypt and absorptive at the surface. As in the small intestine, the colonic crypts contain stem cells, endocrine cells and Paneth cells. In humans, Paneth cells are normally limited to the right colon; their presence in the left colon, which represents metaplasia, is one indicator of chronic disease.
Diarrhea and Paracellular Barriers
Diarrheal disease may be caused by small intestinal or colonic infection. Organisms that preferentially affect the small intestine include Giardia, V. cholera, S. typhi, enterotoxigenic E. coli, and mycobacteria. In contrast, C. difficile, Shigella spp., enterohemorrhagic E. coli, and Campylobacter spp. tend to infect the colon, while Yersinia spp. and Salmonella spp. can affect both small intestine and colon. Detailed discussion of the means by which each of these organisms causes disease is beyond the scope of this article, but mechanisms of pathogenesis include toxin production, bacterial secretion, and invasion. E. coli, Salmonella and Shigella all use a Type III secretion system to transfer bacterial proteins to host cells. In many cases, the injected proteins inhibit small GTPases within host cells, which causes actin reorganization and may enhance endocytic uptake of bacteria. In the case of enteropathogenic E. coli, actin reorganization leads to the characteristic attaching and effacing lesions that concentrate microfilaments beneath bacterial microcolonies. While C. difficile does not use a Type III secretion system, the two major toxins that this organism releases both trigger glucosylation of the small GTPase rho, a critical regulator of cytoskeletal function.41–46 Thus, the actin cytoskeleton is a common target of bacterial pathogens.
The perijunctional actomyosin ring (Fig. 5A) is essential for maintenance of epithelial intercellular junctions. Thus, the massive actomyosin disorganization induced by toxin-mediated rho inhibition results in disassembly of adherens and tight junctions and nearly complete loss of paracellular barrier function.47–49 However, most cases of barrier dysregulation are less extreme and represent altered function of structurally-intact junctions.50–57 This allows increased paracellular flux of hydrophilic solutes, including dietary and microbial antigens and adjuvants, and may contribute to mucosal immune activation and disease.58,59
Figure 5.

Apical enterocyte ultrastructure. (A) Caco-2 cells are frequently used as a model of small intestinal enterocytes due to their extensive differentiation and well-developed microvillus brush border. Each microvillus contains an actin core (arrowhead). A dense perijunctional actomyosin ring excludes organelles, such as mitochondria (arrow) from most apical cytoplasm. Electron micrograph of polarized Caco-2BBe cells98–100 grown on a Transwell support. (B) This high magnification view of the boxed region in (A) shows the apical junctional complex, composed of the tight junction (arrowhead) and adherens junction (arrow). The desmosomes (asterisk) are located more basally.
Tight junctions (Fig. 5B) are composed of multi-protein complexes that include transmembrane proteins, peripheral membrane proteins, and regulatory molecules including kinases and phosphatases.60–65 While the functions of many of these proteins are only beginning to be understood, it is now clear that trans-membrane proteins of the claudin family, which are expressed in a tissue-specific manner, directly impact tight junction permeability.66,67 Claudin proteins form the anastamosing strands that are apparent by freeze-fracture electron microscopic examination of tight junctions,67,68 and individual claudin family members differentially impact paracellular charge selectivity.69–75 Claudins can also be the targets of bacterial toxins. For example, C. perfringens enterotoxin binds to specific claudin proteins and triggers their removal from the tight junction to disrupt barrier function.76–80 Intriguingly, the specific claudin proteins expressed within intestinal epithelia are altered in disease.81–83 Whether this is a beneficial or harmful response remains to be determined.
The roles of occludin, a transmembrane tight junction protein that interacts directly with ZO-1 and actin, are less well understood.84–86 However, removal of occludin from the tight junction by endocytosis is commonly observed in pathological tight junction disruption.2,19,22,52,56,87–91 In vivo, occludin internalization within jejunal enterocytes is elicited by T cell activation as well as systemic administration of recombinant TNF or LIGHT (a member of the TNF core family).19,22 This occludin internalization is associated with subtle reorganization of the scaffold protein ZO-1 at the tight junction,22 increased phosphorylation of perijunctional myosin II regulatory light chain (MLC), and increased paracellular permeability to large hydrophilic solutes.19,22,92 All of these changes, including diarrhea, are prevented by enzymatic or genetic inhibition of myosin light chain kinase (MLCK).22 Pathogenic bacteria, such as enteropathogenic E. coli50,53 and H. pylori;2,93 bacterial products, such as LPS;94 and parasites, such as Giardia may also activate MLCK.54 Thus, MLCK-dependent MLC phosphorylation is a common means of barrier regulation by cytokines and infectious agents.
A recent series of studies in mice has shown that MLCK-dependent barrier loss is necessary for immune-mediated diarrhea19,22 and that constitutive MLCK activation accelerates onset of chronic disease.58 However, these studies also show that tight junction barrier loss alone is insufficient to cause diarrhea; in fact, isolated increases in paracellular permeability enhanced water absorption.19 While this may seem counterintuitive, it is critical to recall that paracellular transport is a passive process driven by transepithelial gradients. Thus, if tight junction permeability to water increases without disruption of the transepithelial osmotic gradient, water absorption may be enhanced.19,95,96 The experimental diarrhea that follows TNF administration or T cell activation requires activation of both MLCK and PKCα.19,22 While MLCK increases paracellular barrier function, PKCα inhibits transcellular sodium absorption. The loss of sodium absorption disrupts the transepithelial osmotic gradient that drives paracellular water absorption, allowing water to flow from mucosa to lumen.19,97
Summary
Although overall themes are maintained, mucosal cellular composition, commensal microbiota, and pathogens vary widely along the length of the gastrointestinal tract. It is, therefore, critical to consider the region involved when assessing disease in humans or animals and to maintain these site-specific relationships when developing reductionist models. Understanding commensal and pathogenic organisms as well as epithelial and immune components of the mucosa is advancing at a rapid pace. Definition of these complex relationships promises to significantly enhance human health.
Acknowledgements
Supported by the NIH (grants R01DK61931, R01DK68271 and P01DK67887).
Footnotes
Previously published online: www.landesbioscience.com/journals/gutmicrobes/article/11427
References
- 1.Baumgartner HK, Montrose MH. Regulated alkali secretion acts in tandem with unstirred layers to regulate mouse gastric surface pH. Gastroenterology. 2004;126:774–783. doi: 10.1053/j.gastro.2003.11.059. [DOI] [PubMed] [Google Scholar]
- 2.Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology. 2009;136:236–246. doi: 10.1053/j.gastro.2008.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Manzo BA, Crabtree JE, Fiona Campbell M, Tweedle D, Potten CS, Bajaj-Elliott M, et al. Helicobacter pylori regulates the expression of inhibitors of DNA binding (Id) proteins by gastric epithelial cells. Microbes Infect. 2006;8:1064–1074. doi: 10.1016/j.micinf.2005.11.003. [DOI] [PubMed] [Google Scholar]
- 4.Hallback DA, Jodal M, Mannischeff M, Lundgren O. Tissue osmolality in intestinal villi of four mammals in vivo and in vitro. Acta Physiol Scand. 1991;143:271–277. doi: 10.1111/j.1748-1716.1991.tb09232.x. [DOI] [PubMed] [Google Scholar]
- 5.Hermiston ML, Green RP, Gordon JI. Chimeric-transgenic mice represent a powerful tool for studying how the proliferation and differentiation programs of intestinal epithelial cell lineages are regulated. Proc Natl Acad Sci USA. 1993;90:8866–8870. doi: 10.1073/pnas.90.19.8866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265. doi: 10.1038/nature07935. [DOI] [PubMed] [Google Scholar]
- 7.Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007. doi: 10.1038/nature06196. [DOI] [PubMed] [Google Scholar]
- 8.van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15–17. doi: 10.1053/j.gastro.2009.05.035. [DOI] [PubMed] [Google Scholar]
- 9.Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, et al. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology. 2009;136:2187–2194. doi: 10.1053/j.gastro.2009.03.002. [DOI] [PubMed] [Google Scholar]
- 10.Gulati AS, Ochsner SA, Henning SJ. Molecular properties of side population-sorted cells from mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2008;294:286–294. doi: 10.1152/ajpgi.00416.2007. [DOI] [PubMed] [Google Scholar]
- 11.Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608–611. doi: 10.1038/nature07602. [DOI] [PubMed] [Google Scholar]
- 12.Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008;8:415–424. doi: 10.1038/nrc2392. [DOI] [PubMed] [Google Scholar]
- 13.Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2009;11:49–50. doi: 10.1038/ni.1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Giesemann T, Guttenberg G, Aktories K. Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology. 2008;134:2049–2058. doi: 10.1053/j.gastro.2008.03.008. [DOI] [PubMed] [Google Scholar]
- 15.Kolachala V, Asamoah V, Wang L, Srinivasan S, Merlin D, Sitaraman SV. Interferon-gamma downregulates adenosine 2b receptor-mediated signaling and short circuit current in the intestinal epithelia by inhibiting the expression of adenylate cyclase. J Biol Chem. 2005;280:4048–4057. doi: 10.1074/jbc.M409577200. [DOI] [PubMed] [Google Scholar]
- 16.Goldstein JL, Sahi J, Bhuva M, Layden TJ, Rao MC. Escherichia coli heat-stable enterotoxin-mediated colonic Cl− secretion is absent in cystic fibrosis. Gastroenterology. 1994;107:950–956. doi: 10.1016/0016-5085(94)90218-6. [DOI] [PubMed] [Google Scholar]
- 17.Vajanaphanich M, Kachintorn U, Barrett KE, Cohn JA, Dharmsathaphorn K, Traynor-Kaplan A. Phosphatidic acid modulates Cl− secretion in T84 cells: varying effects depending on mode of stimulation. Am J Physiol. 1993;264:1210–1218. doi: 10.1152/ajpcell.1993.264.5.C1210. [DOI] [PubMed] [Google Scholar]
- 18.Field M. Intestinal secretion: effect of cyclic AMP and its role in cholera. N Engl J Med. 1971;284:1137–1144. doi: 10.1056/NEJM197105202842008. [DOI] [PubMed] [Google Scholar]
- 19.Clayburgh DR, Musch MW, Leitges M, Fu YX, Turner JR. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest. 2006;116:2682–2694. doi: 10.1172/JCI29218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110:1651–1658. doi: 10.1172/JCI16112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Musch MW, Clarke LL, Mamah D, Gawenis LR, Zhang Z, Ellsworth W, et al. T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. J Clin Invest. 2002;110:1739–1747. doi: 10.1172/JCI15695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest. 2005;115:2702–2715. doi: 10.1172/JCI24970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Boyd M, Bressendorff S, Moller J, Olsen J, Troelsen JT. Mapping of HNF4alpha target genes in intestinal epithelial cells. BMC Gastroenterol. 2009;9:68. doi: 10.1186/1471-230X-9-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lorentz O, Duluc I, Arcangelis AD, Simon-Assmann P, Kedinger M, Freund JN. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol. 1997;139:1553–1565. doi: 10.1083/jcb.139.6.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 2000;119:961–971. doi: 10.1053/gast.2000.18142. [DOI] [PubMed] [Google Scholar]
- 26.Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619–626. doi: 10.1083/jcb.124.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol. 1990;116:177–184. doi: 10.1007/BF01868675. [DOI] [PubMed] [Google Scholar]
- 28.Watson AJ, Chu S, Sieck L, Gerasimenko O, Bullen T, Campbell F, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology. 2005;129:902–912. doi: 10.1053/j.gastro.2005.06.015. [DOI] [PubMed] [Google Scholar]
- 29.Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148–158. doi: 10.1038/nri1777. [DOI] [PubMed] [Google Scholar]
- 30.Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol. 2001;2:1004–1009. doi: 10.1038/ni1101-1004. [DOI] [PubMed] [Google Scholar]
- 31.Schaerer E, Neutra MR, Kraehenbuhl JP. Molecular and cellular mechanisms involved in transepithelial transport. J Membr Biol. 1991;123:93–103. doi: 10.1007/BF01998081. [DOI] [PubMed] [Google Scholar]
- 32.Kraus TA, Brimnes J, Muong C, Liu JH, Moran TM, Tappenden KA, et al. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest. 2005;115:2234–2243. doi: 10.1172/JCI19102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med. 2006;203:2841–2852. doi: 10.1084/jem.20061884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hapfelmeier S, Muller AJ, Stecher B, Kaiser P, Barthel M, Endt K, et al. Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. typhimurium colitis. J Exp Med. 2008;205:437–450. doi: 10.1084/jem.20070633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005;307:254–258. doi: 10.1126/science.1102901. [DOI] [PubMed] [Google Scholar]
- 36.Martens EC, Koropatkin NM, Smith TJ, Gordon JI. Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem. 2009;284:24673–24677. doi: 10.1074/jbc.R109.022848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, et al. Evolution of Symbiotic Bacteria in the Distal Human Intestine. PLoS Biol. 2007;5:156. doi: 10.1371/journal.pbio.0050156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307:1955–1959. doi: 10.1126/science.1109051. [DOI] [PubMed] [Google Scholar]
- 39.Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132–148. doi: 10.3109/00365529609094568. [DOI] [PubMed] [Google Scholar]
- 40.Neut C, Colombel JF, Guillemot F, Cortot A, Gower P, Quandalle P, et al. Impaired bacterial flora in human excluded colon. Gut. 1989;30:1094–1098. doi: 10.1136/gut.30.8.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389–399. doi: 10.1016/0092-8674(92)90163-7. [DOI] [PubMed] [Google Scholar]
- 42.Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995;375:500–503. doi: 10.1038/375500a0. [DOI] [PubMed] [Google Scholar]
- 43.Nobes CD, Hall A. Rho, rac and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell. 1995;81:53–62. doi: 10.1016/0092-8674(95)90370-4. [DOI] [PubMed] [Google Scholar]
- 44.Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) J Biol Chem. 1996;271:20246–20249. doi: 10.1074/jbc.271.34.20246. [DOI] [PubMed] [Google Scholar]
- 45.Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science. 1996;273:245–248. doi: 10.1126/science.273.5272.245. [DOI] [PubMed] [Google Scholar]
- 46.Samarin S, Nusrat A. Regulation of epithelial apical junctional complex by Rho family GTPases. Front Biosci. 2009;14:1129–1142. doi: 10.2741/3298. [DOI] [PubMed] [Google Scholar]
- 47.Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology. 1992;102:416–423. doi: 10.1016/0016-5085(92)90085-d. [DOI] [PubMed] [Google Scholar]
- 48.Nusrat A, Giry M, Turner JR, Colgan SP, Parkos CA, Carnes D, et al. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci USA. 1995;92:10629–10633. doi: 10.1073/pnas.92.23.10629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Jou TS, Schneeberger EE, James Nelson W. Structural and functional regulation of tight junctions by rhoA and rac1 small GTPases. J Cell Biol. 1998;142:101–115. doi: 10.1083/jcb.142.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Shifflett DE, Clayburgh DR, Koutsouris A, Turner JR, Hecht GA. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest. 2005;85:1308–1324. doi: 10.1038/labinvest.3700330. [DOI] [PubMed] [Google Scholar]
- 51.Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology. 2002;123:163–172. doi: 10.1053/gast.2002.34235. [DOI] [PubMed] [Google Scholar]
- 52.Simonovic I, Rosenberg J, Koutsouris A, Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol. 2000;2:305–315. doi: 10.1046/j.1462-5822.2000.00055.x. [DOI] [PubMed] [Google Scholar]
- 53.Yuhan R, Koutsouris A, Savkovic SD, Hecht G. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology. 1997;113:1873–1882. doi: 10.1016/s0016-5085(97)70006-4. [DOI] [PubMed] [Google Scholar]
- 54.Scott KG, Meddings JB, Kirk DR, Lees-Miller SP, Buret AG. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology. 2002;123:1179–1190. doi: 10.1053/gast.2002.36002. [DOI] [PubMed] [Google Scholar]
- 55.Buret AG, Mitchell K, Muench DG, Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology. 2002;125:11–19. doi: 10.1017/s0031182002001853. [DOI] [PubMed] [Google Scholar]
- 56.Obert G, Peiffer I, Servin AL. Rotavirus-induced structural and functional alterations in tight junctions of polarized intestinal Caco-2 cell monolayers. J Virol. 2000;74:4645–4651. doi: 10.1128/jvi.74.10.4645-4651.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Johansen K, Stintzing G, Magnusson KE, Sundqvist T, Jalil F, Murtaza A, et al. Intestinal permeability assessed with polyethylene glycols in children with diarrhea due to rotavirus and common bacterial pathogens in a developing community. J Pediatr Gastroenterol Nutr. 1989;9:307–313. doi: 10.1097/00005176-198910000-00008. [DOI] [PubMed] [Google Scholar]
- 58.Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology. 2009;136:551–563. doi: 10.1053/j.gastro.2008.10.081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809. doi: 10.1038/nri2653. [DOI] [PubMed] [Google Scholar]
- 60.Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006;22:207–235. doi: 10.1146/annurev.cellbio.22.010305.104219. [DOI] [PubMed] [Google Scholar]
- 61.Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006;16:181–188. doi: 10.1016/j.tcb.2006.02.006. [DOI] [PubMed] [Google Scholar]
- 62.Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:1213–1228. doi: 10.1152/ajpcell.00558.2003. [DOI] [PubMed] [Google Scholar]
- 63.Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 2003;4:225–236. doi: 10.1038/nrm1055. [DOI] [PubMed] [Google Scholar]
- 64.Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285–293. doi: 10.1038/35067088. [DOI] [PubMed] [Google Scholar]
- 65.Shen L, Weber CR, Turner JR. The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol. 2008;181:683–695. doi: 10.1083/jcb.200711165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA. 1999;96:511–516. doi: 10.1073/pnas.96.2.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141:1539–1550. doi: 10.1083/jcb.141.7.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol. 1998;143:391–401. doi: 10.1083/jcb.143.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 2001;107:1319–1327. doi: 10.1172/JCI12464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Colegio OR, Van Itallie C, Rahner C, Anderson JM. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol. 2003;284:1346–1354. doi: 10.1152/ajpcell.00547.2002. [DOI] [PubMed] [Google Scholar]
- 71.Van Itallie CM, Fanning AS, Anderson JM. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol. 2003;285:1078–1084. doi: 10.1152/ajprenal.00116.2003. [DOI] [PubMed] [Google Scholar]
- 72.Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem. 2003;278:17350–17359. doi: 10.1074/jbc.M213286200. [DOI] [PubMed] [Google Scholar]
- 73.Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, Anderson JM. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol. 2006;291:1288–1299. doi: 10.1152/ajprenal.00138.2006. [DOI] [PubMed] [Google Scholar]
- 74.Angelow S, Yu AS. Structure-function studies of claudin extracellular domains by cysteine-scanning mutagenesis. J Biol Chem. 2009;284:29205–29217. doi: 10.1074/jbc.M109.043752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Yu AS, Cheng MH, Angelow S, Gunzel D, Kanzawa SA, Schneeberger EE, et al. Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol. 2009;133:111–127. doi: 10.1085/jgp.200810154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Kimura J, Abe H, Kamitani S, Toshima H, Fukui A, Miyake M, et al. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction. J Biol Chem. 2009;285:401–408. doi: 10.1074/jbc.M109.051417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Ling J, Liao H, Clark R, Wong MS, Lo DD. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem. 2008;283:30585–30595. doi: 10.1074/jbc.M803548200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, et al. Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands. Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol. 1999;147:195–204. doi: 10.1083/jcb.147.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Winkler L, Gehring C, Wenzel A, Muller SL, Piehl C, Krause G, et al. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J Biol Chem. 2009;284:18863–18872. doi: 10.1074/jbc.M109.008623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 2000;476:258–261. doi: 10.1016/s0014-5793(00)01744-0. [DOI] [PubMed] [Google Scholar]
- 81.Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis and cell restitution. Gastroenterology. 2005;129:550–564. doi: 10.1016/j.gastro.2005.05.002. [DOI] [PubMed] [Google Scholar]
- 82.Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007;56:61–72. doi: 10.1136/gut.2006.094375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110–1120. doi: 10.1038/labinvest.2008.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777–1788. doi: 10.1083/jcb.123.6.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994;127:1617–1626. doi: 10.1083/jcb.127.6.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745–29753. doi: 10.1074/jbc.273.45.29745. [DOI] [PubMed] [Google Scholar]
- 87.Oshitani N, Watanabe K, Nakamura S, Fujiwara Y, Higuchi K, Arakawa T. Dislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease. Int J Mol Med. 2005;15:407–410. [PubMed] [Google Scholar]
- 88.Shen L, Turner JR. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell. 2005;16:3919–3936. doi: 10.1091/mbc.E04-12-1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFNgamma-induced endocytosis of tight junction proteins: Myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell. 2005;16:5040–5052. doi: 10.1091/mbc.E05-03-0193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Rees LE, Cogan TA, Dodson AL, Birchall MA, Bailey M, Humphrey TJ. Campylobacter and IFNgamma interact to cause a rapid loss of epithelial barrier integrity. Inflamm Bowel Dis. 2008;14:303–309. doi: 10.1002/ibd.20325. [DOI] [PubMed] [Google Scholar]
- 91.Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, et al. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology. 2007;132:2383–2394. doi: 10.1053/j.gastro.2007.02.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119:2095–2106. doi: 10.1242/jcs.02915. [DOI] [PubMed] [Google Scholar]
- 93.Fedwick JP, Lapointe TK, Meddings JB, Sherman PM, Buret AG. Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun. 2005;73:7844–7852. doi: 10.1128/IAI.73.12.7844-7852.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Moriez R, Salvador-Cartier C, Theodorou V, Fioramonti J, Eutamene H, Bueno L. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am J Pathol. 2005;167:1071–1079. doi: 10.1016/S0002-9440(10)61196-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Field M. T cell activation alters intestinal structure and function. J Clin Invest. 2006;116:2580–2582. doi: 10.1172/JCI29985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Turner JR, Clayburgh DR, Musch MW, Leitges M, Fu YX. Response to field. J Clin Invest. 2006;116:3088–3089. doi: 10.1172/JCI29218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Schultheis PJ, Clarke LL, Meneton P, Miller ML, Soleimani M, Gawenis LR, et al. Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet. 1998;19:282–285. doi: 10.1038/969. [DOI] [PubMed] [Google Scholar]
- 98.Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci. 1992;102:581–600. doi: 10.1242/jcs.102.3.581. [DOI] [PubMed] [Google Scholar]
- 99.Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, et al. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol. 1997;273:1378–1385. doi: 10.1152/ajpcell.1997.273.4.C1378. [DOI] [PubMed] [Google Scholar]
- 100.Zhao H, Shiue H, Palkon S, Wang Y, Cullinan P, Burkhardt JK, et al. Ezrin regulates NHE3 translocation and activation after Na+-glucose cotransport. Proc Natl Acad Sci USA. 2004;101:9485–9490. doi: 10.1073/pnas.0308400101. [DOI] [PMC free article] [PubMed] [Google Scholar]

